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OBJECTIVES: To determine whether older adults and
younger adults are equally able to administer home
intravenous antimicrobial infusion therapy (home IV
antimicrobials) without intensive support from home
care agencies.
DESIGN: Retrospective cohort study.
SETTING: Veterans Affairs Ann Arbor Healthcare Sys-
tem, a 100-bed tertiary care medical center.
PARTICIPANTS: All patients who received home IV anti-
microbials from July 1, 2000, through December 31, 2003.
MEASUREMENTS: Demographic data, underlying med-
ical conditions, indications for therapy, antimicrobial
agents administered, concomitant medications, frequency
of patient visits and phone calls, adverse events, and out-
comes of infections.
RESULTS: A total of 205 patients received 231 courses of
home IV antimicrobials, with 107 courses in patients aged
60 and older and 124 courses in patients younger than 60.
For both groups, the most common indication for therapy
was osteoarticular infections, and the predominant patho-
gens were Staphylococcus aureus and coagulase-negative
Staphylococcus. Older patients were significantly more
likely than younger patients to require the assistance of
family members to help with the infusion and were more
likely to be seen in urgent care or to call the infectious
diseases pharmacist or physicians with questions. Overall,
clinical outcomes and numbers of adverse events were sim-
ilar in both groups, with the exception of nephrotoxicity,
which was greater in the older group (P 5.02).
CONCLUSION: With appropriate support from a hospi-
tal-based home IV antimicrobials therapy team, home IV
antimicrobial appears to be a viable option for older adults.
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Serious infections often require extended courses of intra-venous antimicrobial agents. Community-based or
home intravenous antimicrobial infusion therapy (home
IV antimicrobials) provides a convenient and cost-effective
means to complete extended courses of antimicrobial
agents. Increasingly, these agents are administered in the
home setting for many patients, including older adults.1–6
Few studies have specifically addressed concerns unique to
the older adult who receives home IV antimicrobials.7 One
report noted that 72% of older adults were rejected as
candidates for home IV antimicrobials, compared with a
rejection rate of 49% for patients of all ages.1 Concern
exists that older adults, who often have more comorbid
conditions and functional impairment, might be at risk for
more adverse events while administering home IV anti-
microbials. In the private sector, hiring agencies that spe-
cialize in home infusion therapy to oversee the administra-
tion of antimicrobials to older adults can often allay this
concern.
The Veterans Affairs Ann Arbor Healthcare System
differs from many in the private sector in that it does not
contract with home care agencies to supply antimicrobial
agents, perform infusions, or monitor laboratories. Patients
and caregivers are taught the techniques required for
administration of home IV antimicrobials, all drugs and
supplies are provide through the pharmacy, and adverse
events and clinical outcomes are monitored in the infectious
diseases clinic. At every step, this is accomplished with the
help of a dedicated infectious diseases pharmacist who
administers the home IV antimicrobials program (SWW).
The objective of the study was to determine whether
older adults were able to successfully administer home
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IVantimicrobials without intensive support from home care
agencies. The occurrence of adverse events and outcomes in
all patients in the home IV antimicrobials program was
studied, and whether older patients had worse outcomes




The Veterans Affairs (VA) Ann Arbor Healthcare System is
a 100-bed tertiary care medical center. The study popula-
tion included all patients who received home IV anti-
microbials during July 1, 2000, to December 31, 2003.
Study patients were identified using a computerized data-
base maintained by the infectious diseases pharmacist. All
patients had a long-term venous access device (a peripher-
ally inserted central catheter (PICC), a tunneled semi-
permanent central catheter, or an infusion port).
Laboratory studies were monitored when the patients re-
turned to the clinic, which was generally every 2 weeks but
more often if required by the clinical situation. The insti-
tutional review board of the VA Ann Arbor Healthcare
System approved the study.
Overview of the Home IV Antimicrobials Program
The infectious diseases consult team, the infectious diseases
pharmacist, and the inpatient IV therapy team saw patients
who were to be discharged from hospital and receive home
IV antimicrobials. Most patients had PICC lines placed be-
fore discharge; tunneled central venous catheters and infu-
sion ports were rarely used unless there was another
indication, such as a requirement for chemotherapy or par-
enteral nutrition. Before discharge, a member of the IV
therapy team, who verified that a patient could safely per-
form IV infusions at home before the patient was dis-
charged, instructed patients and their families or other
caregivers in infusion techniques. Visiting nurses were avail-
able to change the dressing over the catheter insertion site
each week for some patients; others returned to the infec-
tious diseases clinic weekly to have the dressing changed.
The pharmacist tracked the number of calls to the infectious
diseases pharmacist, nurse case manager, and physicians and
the number of urgent care visits to the facility or other fa-
cilities related to questions about the catheter or infusion.
Study Design and Data Collection
This retrospective review evaluated the pharmacist’s re-
cords, patients’ medical records, dispensing information
from the pharmacy, and microbiology data. For each pa-
tient receiving home IV antimicrobials, the infectious dis-
eases pharmacist prospectively recorded antimicrobial
agents dispensed, details of the IV catheter and insertion
site, adverse events, and overall outcome. Information col-
lected for this analysis included demographic data, under-
lying medical conditions, indications for antimicrobial
therapy, specific antimicrobial agents administered, con-
comitant medications, frequency of patient visits and lab-
oratory testing, adverse events, admissions to hospital or
visits to urgent care for problems related to the catheter or
adverse events, and outcome of the infection.
Definitions of Adverse Events
The following adverse events were recorded: allergic reac-
tions (rash, urticaria, anaphylaxis); nephrotoxicity (increase
in serum creatinine of  1 mg/dL or a doubling of serum
creatinine from with the baseline value on the first day of
outpatient therapy); leukopenia (white blood cell count
o4,000/uL); neutropenia (neutrophils o500/uL); anemia
(hemoglobin o10 mg/dL); thrombocytopenia (platelets
o100,000/uL); and eosinophilia (eosinophils 4500/uL).
Venous access device complications that the record was re-
viewed for were deep venous thrombosis, phlebitis, acciden-
tal removal of the device by the patient, leaking, local
infection, and device-related bloodstream infection.
Statistics
Values were expressed as means  standard deviations. For
adverse events, data were expressed per 1,000 home IV
antimicrobials days. Chi-square, chi-square with continuity
correction, and Fisher exact tests were used to compare




A total of 279 patients who underwent 307 courses of IV
antimicrobial therapy were evaluated for home IV anti-
microbials during the 3.5 years of the study; this included
147 courses of antimicrobial therapy in the older age group
(60) and 160 courses in the younger age group (o60).
There were 40 courses in patients aged 60 and older and 36
courses in patients younger than 60 that were not given as
home IV antimicrobials. In the older group, the predomin-
ant reasons for excluding patients were that they were
deemed incapable of performing the infusion (19/147,
13%) and the IV antimicrobial agent was no longer needed
(14/147, 10%). In the younger group, the predominant
reasons for exclusion were that the IV antimicrobial agent
was no longer needed (18/160, 11%) and that they were
deemed incapable of performing the infusion (8/160, 5%).
A small number of patients in both groups were excluded,
because they were transferred to another facility or they
stayed in the extended care facility to undergo rehabilita-
tion along with IV antimicrobial therapy.
A total of 205 patients received 231 courses of home IV
antimicrobials during July 1, 2000, to December 31, 2003.
Thirteen patients received two separate courses of home IV
antimicrobials, and six patients received three or more cours-
es of home IV antimicrobials. The overall mean age was
58.8  12.2 (range 23–83). Of those aged 60 and older, the
mean age was 68.9  8.9, and 94 patients (46%) received
107 courses of home IVantimicrobials; of those younger than
60, the mean age was 50.6  8.1, and 111 patients (54%)
received 124 courses of home IV antimicrobials. Not unex-
pectedly in a VA population, 99% of patients were men; there
were two women, both younger than 60. The number of
home IV antimicrobials courses increased during the study
period; there were 28 courses in the second half of 2000, 52 in
2001, 72 in 2002, and 79 in 2003.
Underlying medical illnesses were common in younger
and older adults. The most common underlying illnesses
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were diabetes mellitus, coronary artery disease, neuropathy,
and peripheral vascular disease (Table 1). Coronary artery
disease (P 5.01) and congestive heart failure (P 5.01) were
significantly more common in patients aged 60 and older.
Indications for Home IV Antimicrobials
The most common indications for therapy were osteoarti-
cular infections (52%), bacteremias (14%), and skin and
soft-tissue infections (13%) (Table 2). A significant differ-
ence in indications between older and younger age groups
was not observed for home IV antimicrobials, although
there was a trend toward more abdominal abscesses in the
younger group (P 5.06) and more genitourinary tract in-
fections in the older group (P 5.08).
The total days of home IVantimicrobials was 2,643 for
the older adults group and 4,303 for the younger group.
The mean duration of therapy for older adults was
24.7  17 days (median 22 days; range 2–105 days) and
for younger adults was 34.7  42.3 (median 29.5 days;
range 4–450 days). The difference in mean days of therapy
stems partly from one patient in the younger group who
received 450 days of amphotericin B for meningitis and
lumbar epidural abscess due to Coccidioides immitis. With-
out this patient, the mean for the younger group was 31.3
days.
The predominant pathogen for which home IV
antimicrobials were used was Staphylococcus aureus
(39% of all episodes), followed by coagulase-negative
Staphylococcus (23%), Enterococcus faecalis (14%), and
Pseudomonas aeruginosa (13%). Of the S. aureus isolates,
28 (26%) were methicillin resistant (MRSA) in the older
group and 14 (11%) in the younger group (P 5.005). There
were more gram-negative bacilli found in younger patients
than in older patients (53 (43%) vs 29 (27%), P 5.02).
There were no other significant differences found in organ-
isms infecting older and younger patients. In 18 (17%)
older patients and 26 (23%) younger patients, almost all of
whom had osteomyelitis, the etiologic agent was not
known, and emperical antimicrobial treatment was given.
Antimicrobial Therapy
The most common antimicrobial agent for home IV anti-
microbials was vancomycin, which was given for 46% of all
episodes. Cefazolin, ceftriaxone, and ertapenem constituted
the majority of the remaining antimicrobial agents. Ami-
noglycosides were used infrequently (Table 3). Older pa-
Table 1. Underlying Conditions of 205 Patients Receiving 231 Courses of Home Intravenous Antimicrobials
Underlying Condition
Aged 60 (n 5 107) Aged o60 (n 5 124)
P-valueCourses, n (%)
Coronary artery disease 66 (62) 41 (33) .01
Diabetes mellitus 62 (58) 63 (51) .34
Neuropathy 36 (34) 42 (34) .92
Peripheral vascular disease 38 (36) 29 (23) .06
Congestive heart failure 33 (31) 18 (15) .01
Surgery in prior month 19 (18) 16 (13) .40
Chronic renal insufficiency 18 (17) 12 (10) .16
Malignancy 17 (16) 19 (15) .95
Spinal cord injury 7 (7) 8 (7) .81
Stroke 4 (4) 6 (5) .94
Cirrhosis 3 (3) 2 (2) .86
Most patients had more than one underlying condition.
Table 2. Indications for Home Intravenous Antimicrobials in 205 Patients Receiving 231 Courses of Therapy
Type of Infection
Aged 60 (n 5 107) Aged o60 (n 5 124)
P-valueCourses, n (%)
Osteoarticular 56 (52) 64 (52) .98
Bacteremia 17 (16) 15 (12) .52
Cellulitis, subcutaneous abscess 14 (13) 15 (12) .99
Surgical site infection 8 (8) 6 (5) .57
Endocarditis 7 (7) 8 (7) .99
Genitourinary infection 6 (6) 1 (1) .08
Respiratory tract infection 5 (5) 7 (6) .98
Abdominal abscess 1 (1) 8 (7) .06
Otherw 2 (2) 5 (4) .58
 Several courses were associated with more than one infection.
wNeurosyphilis, Coccidioides meningitis, toxoplasmosis, spontaneous bacterial peritonitis, and pericardial abscess.
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tients were more likely than younger patients to be treated
with vancomycin (P 5.02) and ceftazidime (P 5.03).
Concomitant medications did not differ significantly
between older and younger patients. Forty-six patients in
each group received angiotensin-converting enzyme inhib-
itors, and 54 (51%) older adults and 33 (27%) younger
adults received diuretics (P 5.06). Nonsteroidal antiinflam-
matory agents were used in 12 patients (11%) in the older
group and 18 patients (15%) in the younger group.
Intravenous Catheters and Their Care
Overall, 220 of the 231 courses of home IV antimicrobials
were given through a PICC. Five patients in the older group
and five patients in the younger group had a peripheral
catheter (nonindwelling) used for short courses of home IV
antimicrobials, three patients had midline catheters placed,
and four patients each had an infusion port or a Hickman
tunneled catheter. For nine courses, patients required place-
ment of more than one device. No infusion pumps were
used to administer antimicrobials; all patients used gravity
infusion techniques.
For 72 of 231 (31%) courses of home IV an-
timicrobials, the patient performed the infusions without
the help of others. The younger group was significantly
more likely to do this (51/124 episodes, 41%), than the
older group (21/107 episodes, 20%) (Po.001). More com-
monly in the older group, family members or friends per-
formed the infusions (37/107 courses (35%) vs 28/124
courses (23%) in the younger group, P 5.03). The patient,
in concert with a family member or friend, was responsible
for infusions in 30 courses (28%) in the older group and 36
courses (29%) in the younger group. For 10 courses (9%) in
older patients and three courses (2%) in younger patients, a
visiting nurse was available to help with the infusion. A
variety of other arrangements, including urgent care visits
for infusions and varying combinations of family and
friends, made up the remainder. The patient or the family
performed daily inspection of the catheter insertion site; a
visiting nurse changed the catheter site dressing once weekly
for 78 (73%) courses in older patients and 59 (47%) cours-
es in younger patients (Po.001). In the remainder of the
patients, family members, a nearby VA clinic, or the infec-
tious diseases clinic performed dressing changes.
Adverse Events
Nephrotoxicity was observed in 10 courses of home IV
antimicrobials. There was more nephrotoxicity in the older
group (3.0/1,000 home IV antimicrobials days) than in the
younger group (0.5/1,000 home IV antimicrobials days)
(P 5.02) (Table 4). Other adverse events occurred no more
frequently in the older group than in the younger group
(Table 4). Venous access device complications were fre-
quent but rarely serious. The most common event was oc-
clusion of a PICC line, which occurred at a rate of 3.0 per
1,000 home IVantimicrobials days in older patients and 2.3
per 1,000 home IV antimicrobials days in younger patients
Table 3. Antimicrobial Agents Given as Home Intrave-








Vancomycin 58 (54) 47 (38) .02
Ertapenem 13 (12) 17 (14) .88
Cefazolin 11 (10) 17 (14) .55
Ceftriaxone 10 (9) 14 (11) .79
Ceftazidime 12 (11) 4 (3) .03
Piperacillin-tazobactam 6 (6) 8 (7) .99
Ampicillin-sulbactam 4 (4) 13 (11) .08
Aminoglycosides 2 (2) 9 (7) .10
Other agentsw 7 (7) 18 (15) .08
 Some courses involved treatment with more than one agent.
wClindamycin, penicillin, nafcillin, ampicillin, ticarcillin-clavulanic acid,
imipenem, meropenem, and amphotericin B.
Table 4. Adverse Events Noted in 231 Courses of Home Intravenous (IV) Antimicrobials in 205 Patients
Adverse Event
Aged 60 (n 5 107) Aged o60 (n 5 124)
P-valuen (Rate/1,000 Home IV Antimicrobials Days)
Rash 4 (1.51) 4 (0.93) .74
Nephrotoxicity 8 (3.03) 2 (0.46) .02
Eosinophilia 4 (1.51) 5 (1.16) .96
Leukopenia 2 (0.76) 5 (1.16) .96
Anemia 3 (1.14) 2 (0.46) .58
Thrombocytopenia 3 (1.14) 0 .08
Occlusion of catheter 8 (3.03) 10 (2.32) .75
Catheter pulled out 9 (3.41) 13 (3.02) .95
Irritation from dressing 2 (0.76) 4 (0.93) .86
Site infection 2 (0.76) 2 (0.46) .98
Leakage 1 (0.38) 2 (0.46) .67
Bacteremia 2 (0.76) 1 (0.23) .67
Phlebitis 0 1 (0.23) .62
Deep venous thrombosis 0 0 0
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(P 5.7); these events resolved with fibrinolytic agents and
did not require catheter removal. One patient in the young-
er group developed bacteremia with S. aureus related to a
Hickman catheter, and one older patient each developed
Candida parapsilosis fungemia and coagulase-negative
Staphylococcus bacteremia associated with a PICC line.
In all three cases, the catheters were removed, and the in-
fections were successfully treated with antimicrobial
agents. Catheter or infusion problems resulted in hospital
admission during three courses in older patients and two
courses in younger patients.
The number of calls to the infectious diseases team and
the number of urgent care visits related to questions about
the catheter or the infusion differed between older and
younger patients. Older patients were significantly more
likely than younger adults to have a visit to urgent care with
a problem or question related to home IV antimicrobials
(31.4 visits/1,000 home IV antimicrobials days vs 14.3
visits/1,000 home IV antimicrobials days, respectively,
Po.001). Older adults were also more likely than young-
er adults to need intervention from social work service (7.1
encounters/1,000 home IV antimicrobials days vs 2.9 en-
counters/1,000 home IV antimicrobials days, respectively,
P 5.01). Finally, there were more phone calls to the infec-
tious diseases pharmacist from the older group (14.3/1,000
home IV antimicrobials days) than from the younger group
(8.57/1,000 home IV antimicrobials days) (P 5.04).
Outcomes
A total of 27 courses in older patients (25%) and 27 courses
in younger patients (22%) resulted in cure of the infection
by the end of home IVantimicrobials. Overall, 70 courses in
older patients (65%) and 89 courses in younger patients
(72%) were deemed to have stable or improved infection at
the conclusion of intravenous therapy. Oral antimicrobial
therapy, mostly for osteoarticular and complicated skin and
soft-tissue infections, was given when home IV anti-
microbials were finished in patients with stable and im-
proved infection. In only nine courses in older adults (8%)
and seven courses in younger adults (6%) was home IV
antimicrobials considered a failure, and in all of these cases,
failure was attributed to a difficult-to-treat infection and
not to adverse effects encountered during home IV an-
timicrobials.
DISCUSSION
During the past 2 decades, the use of home IV an-
timicrobials has increased greatly. With improving support
networks and growing pressure to decrease hospital lengths
of stay, an increasing number of patients are sent home to
complete their course of antimicrobial therapy. However,
many older individuals still require transfer to a skilled care
facility to receive antimicrobial therapy. This occurs in part
because of concerns that older adults might have more dif-
ficulty with the fine manipulations needed to perform the
infusions or may be unable to understand the nuances of
sterile technique and flushing of the catheter.7 However,
many older adults would prefer to go home than to a skilled
care facility. Given the predominance of older patients
served by the VA healthcare system and the fact that this
system provides total care for most of its patients, this study
was in a unique position to compare the effectiveness and
safety of home IV antimicrobials in a large group of older
adults with that in a younger cohort.
In the home IV antimicrobials program, patients and
their families assume responsibility for storage and mixing
of the antimicrobial agents, infusion of the drug, flushing of
the catheter, and daily observation of the catheter site. The
program is managed through the infectious diseases clinic
and the infectious diseases pharmacist, rather than a home
care agency. For some patients, it was possible to obtain
help from a visiting nurse for a limited number of infusions.
Patients or families who have questions or problems have
easy access to the infectious diseases clinic team, which in-
cludes the pharmacist, the nurse care manager, physicians,
and a social worker.
This study found that both groups experienced fewer
adverse events related to antimicrobial agents than noted in
several previous studies.2,8–12 For example, only eight older
adults and two younger adults experienced nephrotoxicity
during 231 courses of therapy. This may relate partly to the
fact that aminoglycosides were used in 11 patients, of
whom only two were aged 60 and older. Other reports have
included a higher proportion of patients receiving amino-
glycosides as home IV antimicrobials.8 Bone marrow tox-
icity was also infrequently noted and was most often related
to the use of beta-lactam agents. Rash, which was always
associated with the administration of a beta-lactam antibi-
otic, was noted during only four courses in patients in each
age group.
In this study, adverse events related to the catheter were
no different between the age groups, and few were serious.
Only three bloodstream infections were noted, which is less
than noted in other reports.11 This is likely related to the
fact that the patients were not receiving parenteral nutrition
and few were immunosuppressed, which are risk factors for
catheter-related bloodstream infection in patients receiving
home infusion therapy.11 Occlusion of PICCs was common
but resolved in all patients with the use of fibrinolytic ther-
apy. Deep venous thrombosis was not seen in either group.
This is a serious complication of PICC placement and is
likely underdiagnosed.9 Although it is possible that this
complication was missed, few of the patients had the risk
factors found in a previous study to contribute to develop-
ment of great vein thrombosis, namely amphotericin B ad-
ministration, prior history of thrombotic events, and care in
a long-term care facility.9
This review identified a few differences between the
older and younger age groups. The differences that were
noted related almost entirely to the support needed to per-
form the infusions and care for the catheter. In only 20% of
courses in older patients did the patient perform the infu-
sion entirely; most older patients needed a family member
to perform the infusion or to help with certain aspects of
administering the antimicrobial agents. In many cases, this
caregiver was a spouse, who was generally similar in age to
the patient. Older patients also were significantly more
likely than younger patients to call the infectious diseases
team or go to urgent care for advice about the catheter or
the infusion itself.
This study has several potential limitations. It is pos-
sible that older adults who were most adept at understand-
ing the instructions and most facile at performing the
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infusions were predominantly selected. Patients who re-
quired other types of care, such as complicated wound
dressings, were treated in the attached skilled care facility
rather than being offered home IV antimicrobials. Also, all
patients had to perform at a level deemed appropriate by
the IV therapy team before they were able to go home; this
likely selected for more-functional older adults. Whereas
13% of older adults or their caregivers were deemed in-
capable of performing the tasks required for home IV an-
timicrobials, 5% of younger adults or their caregivers were
considered incapable during the study period. Additionally,
it is possible that some patients called their local physician
with questions about the infusion and that there was there-
fore not a record of all of these calls, although it is unlikely
that many calls were missed, because the vast majority of
the patients obtain their primary care from the VA system
and do not have a private physician.
The results show that home IVantimicrobials is a viable
and safe option for older patients. Family members play an
important role in allowing older relatives to come home
from the hospital earlier and to continue to receive appro-
priate antimicrobial therapy. As emphasized in the Infec-
tious Diseases Society of America Guidelines for Outpatient
Parenteral Antimicrobial Therapy,6 assessment of the pa-
tient’s and the caregiver’s abilities to perform home infusion
is crucial to the success of any home infusion program.
There have been only a few problems with the patient or the
caregiver being unable to perform the infusions after dis-
charge. Use of the resources of the VA Healthcare System to
support home IVantimicrobials is effective for care of older
and younger adults.
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